After serving in the United States Marine Corps, Ken earned a B.S. in Chemical Engineering from the University of Rhode Island, a M.S. of Chemical Engineering Practice from M.I.T. and a Ph.D. in Chemical Engineering from Lehigh University where his thesis focused on vibro-fluidization of granular material. He has been a member of AIChE since 1993 and has served on the Delaware Valley Section Board since 2007 where he has held positions as Treasurer, Vice-Chair and Chair. In 2009 he was recognized with an “AIChE Shining Star Award” for his work on the DVS Board. He has also served on the NCEES Chemical Engineering PE Exam Committee since 2009. Ken worked for over 16 years at Merck in vaccine/sterile liquids, solid dosage and packaging development focusing on products like INVANZ®, RotaTeq®, GARDASIL® and solid dosage combination products. Ken then joined Shire to lead the ophthalmic product development group resulting in Xiidra® and other ophthalmic projects. Recently Ken moved to Novartis to enable the transition of Xiidra® from Takeda to Novartis. Ken lives in Gloucester, MA with his wife Rachel, his two kids, his mother-in-law and a goldendoodle named Sandy.